Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receivi...
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents
About this item
Full title
Author / Creator
Seko, Yuya , Moriguchi, Michihisa , Takahashi, Aya , Yamaguchi, Kanji , Umemura, Atsushi , Okuda, Keiichiro , Kataoka, Seita , Unozawa, Hidemi , Kobayashi, Kazufumi , Ogasawara, Sadahisa , Sato, Rui , Tsuchiya, Satoshi , Watanabe, Shunji , Morimoto, Naoki , Iwai, Kenji , Aramaki, Takeshi , Kato, Naoya and Itoh, Yoshito
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
Background
The aim of this multicenter retrospective study was to evaluate the impact of the eradication of hepatitis C virus (HCV) on the clinical outcomes of patients with hepatocellular carcinoma (HCC) treated with molecular-targeted agents (MTAs).
Methods
Among 877 patients who received any MTA as first-line systemic therapy for HCC be...
Alternative Titles
Full title
Hepatitis C virus eradication prolongs overall survival in hepatocellular carcinoma patients receiving molecular-targeted agents
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2620087955
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2620087955
Other Identifiers
ISSN
0944-1174
E-ISSN
1435-5922
DOI
10.1007/s00535-021-01837-5
